Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Azenta, Inc. Market Cap
The Azenta, Inc. (AZTA) share price is expected to increase by 23.67% over the next year. This is based on calculating the average 12-month share price estimate provided by 0 stock analysts who have covered AZTA. Price targets range from $43 at the low end to $79 at the high end. The current analyst consensus for AZTA is a sell. Please note analyst price targets are not guaranteed and could be missed completely.
Azenta, Inc. has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating, the expectation is that Azenta, Inc. will perform worse than the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of AZTA.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Vijay Kumar Evercore ISI Group | In-Line | $50 | Maintains | Oct 1, 2024 |
| David Saxon Needham | Buy | $69 | Reiterates | Aug 7, 2024 |
| Vijay Kumar Evercore ISI Group | In-Line | $53 | Maintains | Jul 2, 2024 |
| David Saxon Needham | Buy | $69 | Maintains | May 9, 2024 |
| David Saxon Needham | Buy | $75 | Maintains | Apr 8, 2024 |
| Vijay Kumar Evercore ISI Group | In-Line | $60 | Maintains | Apr 4, 2024 |
| Matthew Stanton Jefferies | Hold | $64 | Initiates | Apr 4, 2024 |
| David Saxon Needham | Buy | $75 | Reiterates | Mar 28, 2024 |
| David Saxon Needham | Buy | $75 | Maintains | Mar 14, 2024 |
| David Saxon Needham | Buy | $75 | Reiterates | Mar 7, 2024 |
| David Saxon Needham | Buy | $75 | Maintains | Feb 8, 2024 |
| Jacob Johnson Stephens & Co. | Equal-Weight | $70 | Reiterates | Feb 8, 2024 |
| Yuan Zhi B. Riley Securities | Buy | $79 | Maintains | Feb 1, 2024 |
| David Saxon Needham | Buy | $76 | Maintains | Jan 18, 2024 |
| David Saxon Needham | Buy | $68 | Reiterates | Nov 14, 2023 |
| Jacob Johnson Stephens & Co. | Equal-Weight | $55 | Reiterates | Nov 14, 2023 |
| David Saxon Needham | Buy | $65 | Maintains | Aug 9, 2023 |
| Jacob Johnson Stephens & Co. | Equal-Weight | $45 | Reiterates | Aug 9, 2023 |
Raymond James | Market Perform | Initiates | Jul 19, 2023 | |
| David Saxon Needham | Buy | $55 | Maintains | May 10, 2023 |
When did it IPO
2011
Staff Count
3,300
Country
United States
Sector/Industry
Healthcare/Medical Instruments & Supplies
CEO
Mr. John P. Marotta
Market Cap
$2.32B
In 2023, AZTA generated $665.1M in revenue, which was a increase of 19.73% from the previous year. This can be seen as a signal that AZTA's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Wed, 04 Sep 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Azenta, Inc. announced the appointment of John P. as the new leader, succeeding Dr. Stephen Schwartz after a 14-year tenure.
Why It Matters - A leadership change at Azenta may signal strategic shifts, impacting company performance and stock volatility, which are crucial factors for investment decisions.
Mon, 12 Aug 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Azenta, Inc. (Nasdaq: AZTA) will celebrate the 25th anniversary of GENEWIZ Multiomics and Synthesis Solutions and host GENEWIZ Week from September 16-20, 2024.
Why It Matters - The 25th anniversary and GENEWIZ Week launch highlight Azenta's growth and innovation, potentially boosting investor confidence and interest in the company's future prospects.
Tue, 06 Aug 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - Azenta, Inc. (NASDAQ: AZTA) will hold its Q3 2024 Results Conference Call on August 6, 2024, at 4:30 PM ET, featuring key executives and analysts from various firms.
Why It Matters - The Q3 2024 results and conference call provide insights into Azenta's financial performance, strategic direction, and management's outlook, influencing investor sentiment and stock valuation.
Tue, 06 Aug 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Azenta, Inc. (Nasdaq: AZTA) reported its financial results for Q3 2024, ending June 30. Further details on performance can be expected in the full report.
Why It Matters - Azenta, Inc.'s Q3 financial results can impact stock performance, influencing investor sentiment and potential future earnings projections.
Tue, 06 Aug 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - Azenta (AZTA) reported Q4 earnings of $0.16 per share, surpassing the Zacks Consensus Estimate of $0.07 and up from $0.13 per share in the prior year.
Why It Matters - Azenta's earnings beat expectations and show year-over-year growth, indicating strong performance and potential for continued investor confidence and stock price appreciation.
Mon, 05 Aug 2024
Sentiment - NEUTRAL
Source - PRNewsWire
Summary - Azenta, Inc. (Nasdaq: AZTA) will participate in the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12, 2024.
Why It Matters - Azenta's participation in the MedTech conference suggests potential visibility and networking opportunities, which could impact future partnerships, investments, and stock performance.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
